Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA-Reference-Cited by-同舟云学术

Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA

Published:2016-06-28 Issue:19 Volume:122 Page:3015-3023
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Hayashi Masanori¹,Chu David¹,Meyer Christian F.¹,Llosa Nicolas J.¹,McCarty Gregory¹,Morris Carol D.²,Levin Adam S.²,Wolinsky Jean-Paul³,Albert Catherine M.¹,Steppan Diana A.¹,Park Ben Ho¹,Loeb David M.¹

Affiliation:

1. Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins University; Baltimore Maryland

2. Department of Orthopaedic Surgery; Johns Hopkins University School of Medicine; Baltimore Maryland

3. Department of Neurosurgery; Johns Hopkins University School of Medicine; Baltimore Maryland

Funder

Sidney Kimmel Comprehensive Cancer Center

National Institutes of Health

The Rally Foundation for Childhood Cancer Research

The Pediatric Cancer Foundation

Liddy Shriver Sarcoma Initiative

The Giant Food Children's Cancer Research Fund

Pablove Foundation and by the Sarcoma Alliance for Research through Collaboration (SARC) Sarcoma SPORE Career Development Award

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference22 articles.

1. Five-year survival of patients with Ewing's sarcoma;Falk;Surg Gynecol Obstet,1967

2. Proceedings: disease-free survival in children with Ewing's sarcoma treated with radiation therapy and adjuvant four-drug sequential chemotherapy;Rosen;Cancer,1974

3. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group;Womer;J Clin Oncol,2012

4. Detection of circulating tumor DNA in early- and late-stage human malignancies;Bettegowda;Sci Transl Med,2014

5. St Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project and the International Cancer Genome Consortium. Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations;Tirode;Cancer Discov,2014

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric Leukemia Roadmaps Are a Guide for Positive Metastatic Bone Sarcoma Trials;Journal of Clinical Oncology;2024-09-01

2. Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board;Cancer;2024-08-25

3. A comprehensive overview of liquid biopsy applications in pediatric solid tumors;npj Precision Oncology;2024-08-03

4. Cadherin-11 contributes to the heterogenous and dynamic Wnt-Wnt-β-catenin pathway activation in Ewing sarcoma;PLOS ONE;2024-06-14

5. Opportunity in Complexity: Harnessing Molecular Biomarkers and Liquid Biopsies for Personalized Sarcoma Care;Seminars in Radiation Oncology;2024-04